High-flying growth stocks like Bionano Genomics (NASDAQ: BNGO) tend to be controversial among different crowds of investors. Where some might see a stock's potential to multiply in value over time by pioneering new technologies or new business models, others might see the unbounded risk that's associated with trying something new. 

But which crowd is right about Bionano? In truth, both sides have a point when it comes to this stock. Let's explore why.

Image source: Getty Images.

Continue reading


Source Fool.com